全文获取类型
收费全文 | 2226篇 |
免费 | 109篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 44篇 |
妇产科学 | 50篇 |
基础医学 | 232篇 |
口腔科学 | 67篇 |
临床医学 | 155篇 |
内科学 | 525篇 |
皮肤病学 | 67篇 |
神经病学 | 217篇 |
特种医学 | 160篇 |
外科学 | 371篇 |
综合类 | 9篇 |
预防医学 | 85篇 |
眼科学 | 30篇 |
药学 | 82篇 |
中国医学 | 1篇 |
肿瘤学 | 230篇 |
出版年
2023年 | 24篇 |
2022年 | 41篇 |
2021年 | 102篇 |
2020年 | 44篇 |
2019年 | 37篇 |
2018年 | 79篇 |
2017年 | 49篇 |
2016年 | 65篇 |
2015年 | 68篇 |
2014年 | 88篇 |
2013年 | 111篇 |
2012年 | 190篇 |
2011年 | 162篇 |
2010年 | 80篇 |
2009年 | 88篇 |
2008年 | 130篇 |
2007年 | 146篇 |
2006年 | 125篇 |
2005年 | 153篇 |
2004年 | 117篇 |
2003年 | 122篇 |
2002年 | 97篇 |
2001年 | 16篇 |
2000年 | 10篇 |
1999年 | 19篇 |
1998年 | 27篇 |
1997年 | 16篇 |
1996年 | 19篇 |
1995年 | 14篇 |
1994年 | 12篇 |
1993年 | 7篇 |
1992年 | 6篇 |
1991年 | 7篇 |
1990年 | 4篇 |
1989年 | 6篇 |
1988年 | 3篇 |
1986年 | 4篇 |
1985年 | 5篇 |
1984年 | 7篇 |
1982年 | 2篇 |
1981年 | 5篇 |
1980年 | 2篇 |
1977年 | 3篇 |
1974年 | 2篇 |
1958年 | 4篇 |
1957年 | 3篇 |
1956年 | 5篇 |
1955年 | 3篇 |
1917年 | 1篇 |
1914年 | 1篇 |
排序方式: 共有2344条查询结果,搜索用时 15 毫秒
91.
Angiogenesis is essential for bone formation and several bone morphogenetic proteins (BMPs) have been shown to induce angiogenesis through osteoblast-derived vascular endothelial growth factor (VEGF)-A. Growth differentiation factor-5 (GDF-5) is a member of the BMP family expressed in bone and known to induce angiogenesis in vivo. In this study, the effects of GDF-5 on osteogenic differentiation and expression of VEGF-related genes were determined using rat bone marrow stromal cells. GDF-5 stimulated osteogenic differentiation. It also upregulated the expression of VEGF-A after 3 hr, accompanied by a trend of decrease in its receptor VEGFR-2 at 6 and 24 hr. VEGF-D and its receptor VEGFR-3 showed peak expression at later time points. This regulation may be further controlled by neuropilin 2 that exhibited a parallel profile to VEGF-D. These observations indicate that GDF-5 stimulates osteogenic differentiation and has a potential to induce angiogenesis through osteoblast-derived VEGF-A in bone. 相似文献
92.
93.
Yoshihiro Dogaki Sang Yang Lee Takahiro Niikura Takashi Iwakura Etsuko Okumachi Takahiro Waki Kenichiro Kakutani Kotaro Nishida Ryosuke Kuroda Masahiro Kurosaka 《International orthopaedics》2014,38(9):1779-1785
Purpose
There has been great interest in the use of induced pluripotent stem cells (iPSCs) in bone regenerative strategies. To generate osteoprogenitor cells from iPSCs, the most widely used protocol relies on an intermediate using embryoid body (EB) formation. We hypothesized that an osteoprogenitor cell population could be efficiently generated from iPSCs by employing a “direct-plating method” without the EB formation step.Methods
Murine iPSC colonies were dissociated with trypsin-EDTA, and obtained single cells were cultured on gelatin-coated plates in MSC medium and FGF-2. Adherent homogeneous fibroblast-like cells obtained by this direct-plating technique were termed as direct-plated cells (DPCs). Expression levels of Oct-3/4 mRNA were analysed by real-time PCR. DPCs were evaluated for cell-surface protein expression using flow cytometry. After osteogenic induction, osteogenic differentiation ability of DPCs was evaluated.Results
The expression level of Oct-3/4 in DPCs was significantly down-regulated compared to that observed in iPSCs, suggesting that the cells lost pluripotency. Flow cytometry analysis revealed that DPCs exhibited cell-surface antigens similar to those of bone marrow stromal cells. Furthermore, the cells proved to have a high osteogenic differentiation capacity, which was confirmed by the significant increase in alkaline phosphatase activity, the expression levels of osteogenic genes, and calcium mineralization after 14-day osteogenic induction.Conclusions
These findings indicate that our novel direct-plating method provides a clinically applicable, simple, and labour-efficient system for generating large numbers of homogeneous iPSC-derived osteoprogenitor cells for bone regeneration. 相似文献94.
Kotaro Maeda Tsunekazu Hanai Harunobu Sato Koji Masumori Yoshikazu Koide Hiroshi Matsuoka Hidetoshi Katsuno Makoto Kuroda 《Surgery today》2014,44(2):297-301
Purposes
To establish the efficiency of bowel ligatures in colon cancer surgery, focusing on the extent to which exfoliated cancer cells are shed in the colonic lumen during sigmoidectomy.Methods
Twenty consecutive patients who underwent sigmoidectomy for sigmoid colon cancer were prospectively randomized into two groups: the “ligatures group”, in which bowel ligatures were placed, 3, 5, 10 cm from the tumor proximally and distally before dissection; and the “no ligatures group”, in which the corresponding sites were ligated only immediately before taking the specimen out. Each colonic segment ligated was irrigated with saline and samples were sent for blind cytological examination.Results
Cancer cells were found in the colonic segment where the tumor was located, in 18 of 20 samples. The frequency of free cancer cells decreased from 50 to 0 % (p < 0.04) in the distal 3–5 cm colonic segment and from 80 to 20 % (p < 0.03) in the proximal colonic segment after performing bowel ligatures. Free cancer cells were confirmed in 1 of 10 samples at both colonic segments 5–10 cm from the tumor, even after bowel ligatures.Conclusions
Intraluminal exfoliated cancer cells could be eliminated by placing bowel ligatures during sigmoidectomy. Measures should be considered to eliminate exfoliated cancer cells during colectomy, even after placing bowel ligatures. 相似文献95.
Critical neuroprotective roles of heme oxygenase‐1 induction against axonal injury‐induced retinal ganglion cell death
下载免费PDF全文
![点击此处可从《Journal of neuroscience research》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Noriko Himori Kazuichi Maruyama Kotaro Yamamoto Masayuki Yasuda Morin Ryu Kazuko Omodaka Yukihiro Shiga Yuji Tanaka Toru Nakazawa 《Journal of neuroscience research》2014,92(9):1134-1142
Although axonal damage induces significant retinal ganglion cell (RGC) death, small numbers of RGCs are able to survive up to 7 days after optic nerve crush (NC) injury. To develop new treatments, we set out to identify patterns of change in the gene expression of axonal damage‐resistant RGCs. To compensate for the low density of RGCs in the retina, we performed retrograde labeling of these cells with 4Di‐10ASP in adult mice and 7 days after NC purified the RGCs with fluorescence‐activated cell sorting. Gene expression in the cells was determined with a microarray, and the expression of Ho‐1 was determined with quantitative PCR (qPCR). Changes in protein expression were assessed with immunohistochemistry and immunoblotting. Additionally, the density of Fluoro‐gold‐labeled RGCs was counted in retinas from mice pretreated with CoPP, a potent HO‐1 inducer. The microarray and qPCR analyses showed increased expression of Ho‐1 in the post‐NC RGCs. Immunohistochemistry also showed that HO‐1‐positive cells were present in the ganglion cell layer (GCL), and cell counting showed that the proportion of HO‐1‐positive cells in the GCL rose significantly after NC. Seven days after NC, the number of RGCs in the CoPP‐treated mice was significantly higher than in the control mice. Combined pretreatment with SnPP, an HO‐1 inhibitor, suppressed the neuroprotective effect of CoPP. These results reflect changes in HO‐1 activity to RGCs that are a key part of RGC survival. Upregulation of HO‐1 signaling may therefore be a novel therapeutic strategy for glaucoma. © 2014 Wiley Periodicals, Inc. 相似文献
96.
97.
Yuichiro Yamada Tatsuhito Himeno Kotaro Tsuboi Yuka Shibata Miyuka Kawai Yuriko Asada-Yamada Yusuke Hayashi Emi Asano-Hayami Tomohide Hayami Yuichiro Ishida Yohei Ejima Mikio Motegi Saeko Asano Makoto Kato Eriko Nagao Hiromi Nakai-Shimoda Takahiro Ishikawa Yoshiaki Morishita Masaki Kondo Shin Tsunekawa Yoshiro Kato Takayuki Nakayama Motohiro Kamei Jiro Nakamura Hideki Kamiya 《Journal of diabetes investigation.》2021,12(8):1430-1441
98.
Masahiko Noguchi MD Minoru Tabata MD Kotaro Obunai MD Kentaro Shibayama MD Joji Ito MD Hiroyuki Watanabe MD Fumiaki Yashima MD Yusuke Watanabe MD Toru Naganuma MD Motoharu Araki MD Futoshi Yamanaka MD Shinichi Shirai MD Hiroshi Ueno MD Kazuki Mizutani MD Akihiro Higashimori MD Kensuke Takagi MD Norio Tada MD Masanori Yamamoto MD Kentaro Hayashida MD 《Catheterization and cardiovascular interventions》2021,97(1):E113-E120
99.
Yada H Sato T Soejima K Jo Y Jinzaki M Togashi I Nakamizo H Fukumoto K Tanimoto K Miyoshi S Kuribayashi S Ogawa S 《Circulation》2008,117(17):2297-2298
100.
Michael R. Waterman Kotaro Yamaoka Larry Dahm Joe Taylor G. L. Cottam 《Proceedings of the National Academy of Sciences of the United States of America》1974,71(6):2222-2225
Ammonium sulfate, as well as potassium phosphate, can be used to measure solubility differences between hemoglobin S and hemoglobin A. In addation, the solubility of deoxyhemoglobin C(Harlem) in 1.96 M phosphate has a markedly different temperature dependence from that of deoxyhemoglobin S. This observation indicates that the solubility measurement is quite sensitive to changes in protein structure. Because of the large degree of comparability between the solubility and the aggregation of deoxyhemoglobin S, solubility was used to measure the effectiveness of organic compounds as noncovalent modifiers of deoxyhemoglobin S aggregation.Organic solvents (ethanol, dimethylsulfoxide, 1,4-dioxane, dimethylformamide) alter the solubility characteristics of deoxyhemoglobin S in 1.96 M phosphate buffer, pH 7.0. The concentrations of solvent necessary to provide a half-maximal effect are remarkably similar (about 0.5 M), although the chemical nature of these compounds is quite different. The effect of these solvents must be to prevent the noncovalent bond formation necessary to produce the insoluble hemoglobin precipitate, perhaps by altering the water structure around the deoxyhemoglobin S molecules. In addition to these organic solvents, guanidine hydrochloride and urea, two well-known protein denaturants, were studied. Guanidine hydrochloride was as effective as the best organic solvent in increasing the solubility of deoxyhemoglobin S; urea was far less effective. Studies in vitro with intact erythrocytes from individuals homozygous for hemoglobin S showed that sickling is decreased up to 50% by treatment with ethanol. This offers further evidence that solubility is monitoring a phenomenon similar to the aggregation of deoxyhemoglobin S inside erythrocytes. While use of these particular compounds in vitro would seem to have no clinical implications, these studies do suggest that the use of chemicals that do not modify hemoglobin S covalently should be explored in efforts to prevent deoxyhemoglobin S aggregation. 相似文献